Service Communautaire d'Information sur la Recherche et le Développement - CORDIS

ADvanced Validation of A Novel TB Active disease diagnostic to address Global unmet needs: a European consortium approach

De 2015-07-01 à 2018-06-30, projet en cours

Détails concernant le projet

Coût total:

EUR 3 893 307,50

Contribution de l'UE:

EUR 3 583 396

Coordonné à/au(x)/en:

United Kingdom

Appel à propositions:

H2020-SMEINST-2-2014See other projects for this call

Régime de financement:

SME-2 - SME instrument phase 2

Objectif

Coordinateur

PROTEINLOGIC LIMITED
United Kingdom

Contribution de l'UE: EUR 2 921 750


SHAKESPEARE HOUSE 42 NEWMARKET ROAD
CB5 8EP CAMBRIDGE CAMBRIDGESHIRE
United Kingdom
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)

Participants

BIOSENSIA LIMITED
Ireland

Contribution de l'UE: EUR 661 646


MARDYKE PARADE 9
4 CORK
Ireland
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)